Biotechnology
Deconstructing Moderna’s COVID-19 Patent Pledge
In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.
Deconstructing Moderna’s COVID-19 Patent Pledge



